著者: HampelPaul J, CallTimothy G, RabeKari G, DingWei, MuchtarEli, KenderianSaad S, WangYucai, LeisJose F, WitzigThomas E, KoehlerAmber B, FonderAmie L, SchwagerSusan M, Van DykeDaniel L, BraggioEsteban, SlagerSusan L, KayNeil E, ParikhSameer A

原題: Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.

著者: BaptisteFlorian, CautelaJennifer, AncedyYan, ResseguierNoémie, AurranThérèse, FarnaultLaure, EscudierMarion, AmmarChloé, GaubertMélanie, DolladilleCharles, BarraudJeremie, PeyrolMichael, CohenAriel, PaganelliFranck, AlexandreJoachim, EderhyStephane, ThunyFranck

原題: High incidence of atrial fibrillation in patients treated with ibrutinib.

著者: BohnMarcela, Bravo-LjubeticLuciano, LeeRichard W J, PetrushkinHarry

原題: Ibrutinib-related uveitis: A report of two severe cases.

著者: SzászRóbert, IllésÁrpád

原題: Interdisciplinary approach to the current management of chronic lymphocytic leukemia

著者: PellegriniLuca, NovakUrban, AndresMartin, SuterThomas, NaglerMichael

原題: Risk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis.

著者: KorkmazMustafa, Karakurt EryilmazMelek, KaraağaçMustafa, ArazMurat, ÇeneliÖzcan, ArtaçMehmet

原題: Ibrutinib and panitumumab used in combination safely in a patient with metachronous colorectal cancer and chronic lymphocytic leukemia.

著者: YorulmazAhu, YalcinBasak

原題: Paronychia and Periungual Granulation as a Novel Side Effect of Ibrutinib: A Case Report.

著者: StühlingerMarkus C, WeltermannAnsgar, StaberPhilipp, HeintelDaniel, NösslingerThomas, SteurerMichael

原題: Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk.

著者: CömertPınar, AlbayrakMurat, YıldızAbdulkerim, ŞahinOsman, ÖztürkHacer Berna, Reis ArasMerih

原題: Ibrutinib-induced polyneuropathy: A case report.

著者: DouDou, ShaWenjie, DiaoYanyan, SuRongrong, QiaoYunjin, YuZhixiao, ZhaoZhenjiang, LiHonglin, ChenZhuo, XuYufang

原題: Discovery of pyrido[3,4-b]indol-1-one derivatives as novel non-covalent Bruton's tyrosine kinase (BTK) inhibitors.

著者: HtutThura Win, HanMyat Min, TheinKyaw Zin

原題: Acalabrutinib-Related Cardiac Toxicities in Patients with Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials.

著者: MazoriAlon Yehuda, SkamagasMaria

原題: Increased Thyroid-Hormone Requirements Consistent With Type 3 Deiodinase Induction Related to Ibrutinib in a Thyroidectomized Woman.

著者: AghelNazanin, Baro VilaRocio C, LuiMichelle, HillisChristopher, LeongDarryl P

原題: Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors.

著者: HigerMaximilian, CanaDenis, PodlechJuergen, Schadmand-FischerSimin, SchwartingAndreas, TeschnerDaniel, TheobaldMatthias, WölfelThomas, HessGeorg

原題: Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report.

著者: AlexanderWilliam, DavisSarah, RamakrishnaRaj, ManoharanArumugam

原題: Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study.

著者: PalmaMarzia, MulderTom A, ÖsterborgAnders

原題: BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects.

著者: FrustaciAnna M, TedeschiAlessandra, DeodatoMarina, ZamprognaGiulia, CairoliRoberto, MontilloMarco

原題: Duvelisib: a new phosphoinositide-3-kinase inhibitor in chronic lymphocytic leukemia.

著者: von HundelshausenPhilipp, SiessWolfgang

原題: Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease.

著者: JohnsonGrace, BaviriseatyNiharika, MassanetNicholas, KooperJeffrey

原題: Serositis causing pericardial and pleural effusions after eight years of maintenance ibrutinib for Waldenstrom's macroglobulinemia.

著者: WangSicong, ClapperErin, TonissenKathryn F, Di TrapaniGiovanna

原題: Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma.

著者: MolicaStefano, TamConstantine, AllsupDavid, PolliackAaron

原題: Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option.

著者: MuñozJavier, SarosiekShayna, CastilloJorge J

原題: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies.

著者: MoschosStergios J, ErogluZeynep, KhushalaniNikhil I, KendraKari L, AnsstasGeorge, InGino K, WangPeng, LiuGlenn, CollichioFrances A, GoogePaul B, CarsonCraig C, McKinnonKaren, WangHsing-Hui, Nikolaishvilli-FeinbergNana, IvanovaAnastasia, ArrowoodChristy C, Garrett-MeadNancy, ConwayKathleen C, EdmistonSharon N, OllilaDavid W, SerodyJonathan S, ThomasNancy E, IvyS Percy, AgrawalLokesh, DeesElizabeth C, AbbruzzeseJames L

原題: Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).

著者: KabadiShaum M, NearAimee, WadaKeiko, BurudpakdeeChakkarin

原題: Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States.

著者: DeSurya K

原題: Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults.

著者: ZhangJing, LuXueying, LiJianyong, MiaoYi

原題: Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma.

著者: LiuJiakuo, ChenChengjuan, WangDongmei, ZhangJie, ZhangTiantai

原題: Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development.

著者: EmelinaE I, GendlinG E, NikitinI G

原題: [Пятилетнее исследование влияния кардиомониторинга на общую выживаемость больных хроническим лимфолейкозом, получающих таргетную терапию ибрутинибом].